GLMD Company Profile and Key Details
Galmed Pharmaceuticals Ltd.
GLMD Stock Price Chart
Stock Price Today
Galmed Pharmaceuticals Ltd. (GLMD) stock declined over -0.35%, trading at $2.85 on NASDAQ, down from the previous close of $2.86. The stock opened at $2.90, fluctuating between $2.85 and $2.94 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinical trial with HIV-associated non-alcoholic fatty liver disease and lipodystrophy. In addition, it engages in the development of Amilo-5MER, a 5 amino acid synthetic peptide methionine, threonine, alanine, aspartic acid, and valine. It has a research agreement with Gannex Pharma Co., Ltd. to develop a combination therapy of ASC41 (THR-beta agonist) and Aramchol (SCD 1 inhibitor) for the treatment of NASH; a research and development collaboration agreement with MyBiotics Pharma Ltd. to identify the selected microbiome repertoire associated with the response to Aramchol; and a license agreement with Samil Pharma. Co., Ltd. for the commercialization of Aramchol in the Republic of Korea. Galmed Pharmaceuticals Ltd. was founded in 2000 and is headquartered in Tel Aviv, Israel.
Company Information
| Employees | 3 |
| Beta | 0.8 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | -1% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) stock price is $2.85 in the last trading session. During the trading session, GLMD stock reached the peak price of $2.94 while $2.85 was the lowest point it dropped to. The percentage change in GLMD stock occurred in the recent session was -0.35% while the dollar amount for the price change in GLMD stock was -$0.01.
The NASDAQ listed GLMD is part of Biotechnology industry that operates in the broader Healthcare sector. Galmed Pharmaceuticals Ltd. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Ms. Yael Hollander
Vice President of Legal Affairs & Strategy
Mr. Doron Cohen
Chief Financial Officer
Mr. Yohai Stenzler CPA
Chief Accounting Officer
Mr. Allen Baharaff
Co-Founder, Pres, Chief Executive Officer & Chairman
Mr. Niv Alon
Head of PMO
Ms. Shani Ganon
HR Mang.
Mr. Guy Nehemya
Chief Operating Officer & Data Protection Officer
Dr. Liat Hayardeny
Chief Scientific Officer
Dr. Tali Gorfine
Medical Consultant
GLMD's closing price is 11.32% higher than its 52-week low of $2.56 where as its distance from 52-week high of $23.80 is -88.03%.
Number of GLMD employees currently stands at 3.
Official Website of GLMD is: https://www.galmedpharma.com
GLMD could be contacted at phone 972 369 38448 and can also be accessed through its website. GLMD operates from 16 Tiomkin Street, Tel Aviv, 6578317, Israel.
GLMD stock volume for the day was 4.96K shares. The average number of GLMD shares traded daily for last 3 months was 50.81K.
The market value of GLMD currently stands at $4.72M with its latest stock price at $2.85 and 1.66M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com